Incorporating genetics and genomics in risk assessment for inhaled manganese: From data to policy

NeuroToxicology

Volumn 30, Issue 5, 2009, Pages 754-760

  Curran, Christine P ^a   Park, Robert M ^b   Ho, Shuk mei ^c   Haynes, Erin N ^c  

^a NORTHERN KENTUCKY UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

DNA; Epidemiology; Genetic susceptibility; Manganese; Occupational health; Policy

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA SYNUCLEIN; BIOLOGICAL MARKER; CYTOCHROME P450 2D6; GLUTAMATE CYSTEINE LIGASE; GLUTAMATE DECARBOXYLASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HEME OXYGENASE; HOMEODOMAIN PROTEIN; MANGANESE; METALLOTHIONEIN; NEUROGENIC DIFFERENTIATION FACTOR; PARKIN; PROGESTERONE RECEPTOR; PROTEIN SERINE THREONINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GOVERNMENT; HUMAN; HUMAN GENOME PROJECT; IN VIVO STUDY; MEDICAL RESEARCH; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TOXICOGENETICS; TOXICOKINETICS; TRANSCRIPTOMICS; WELDING FUME;

GENETICS; GENOMICS; HUMANS; INHALATION EXPOSURE; MANGANESE; MANGANESE POISONING; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH (U.S.); OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; UNITED STATES;

PARKINSONIA;

EID: 70349734336     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.07.013     Document Type: Article

References (116)

1. Agency for Toxic Substances and Disease Registry. Health Consultation: Washington County Air Quality, Marietta, Ohio, 18-6-2007. Atlanta, GA: U.S. Department of Health and Human Services. 31-3-2009.
2. Akbas N., Hochstrasser H., Deplazes J., Tomiuk J., Bauer P., Walter U., et al. Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci Lett 407 1 (2006) 16-19
3. Anderson J.G., Cooney P.T., and Erikson K.M. Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. Environ Toxicol Pharmacol 23 2 (2007) 179-184
4. Anger W.K. Neurobehavioural tests and systems to assess neurotoxic exposures in the workplace and community. Occup Environ Med 60 7 (2003) 531-8, 474
5. Aschner M. Manganese homeostasis in the CNS. Environ Res 80 2 Pt 1 (1999) 105-109
6. Aschner M. Manganese: brain transport and emerging research needs. Environ Health Perspect 108 Suppl. 3 (2000) 429-432
7. Aschner M., and Aschner J.L. Manganese transport across the blood-brain barrier: relationship to iron homeostasis. Brain Res Bull 24 6 (1990) 857-860
8. Aschner M., and Dorman D.C. Manganese: pharmacokinetics and molecular mechanisms of brain uptake. Toxicol Rev 25 3 (2006) 147-154
9. Aschner M., Guilarte T.R., Schneider J.S., and Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 221 2 (2007) 131-147
10. Aschner M., Lukey B., and Tremblay A. The Manganese Health Research Program (MHRP): status report and future research needs and directions. Neurotoxicology 27 5 (2006) 733-736
11. Barhoumi R., Faske J., Liu X., and Tjalkens R.B. Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor kappaB. Brain Res Mol Brain Res 122 2 (2004) 167-179
12. Bellinger D.C. Perspectives on incorporating human neurobehavioral end points in risk assessments. Risk Anal 23 1 (2003) 163-174
13. Bon M.A., Jansen Steur E.N., de Vos R.A., and Vermes I. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism. Neurosci Lett 266 2 (1999) 149-151
14. Bowler R.M., Gysens S., Diamond E., Booty A., Hartney C., and Roels H.A. Neuropsychological sequelae of exposure to welding fumes in a group of occupationally exposed men. Int J Hyg Environ Health 206 6 (2003) 517-529
15. Bowler R.M., Nakagawa S., Drezgic M., Roels H.A., Park R.M., Diamond E., et al. Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. Neurotoxicology 28 2 (2007) 298-311
16. Bowler R.M., Roels H.A., Nakagawa S., Drezgic M., Diamond E., Park R., et al. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 64 3 (2007) 167-177
17. Budovsky A., Muradian K.K., and Fraifeld V.E. From disease-oriented to aging/longevity-oriented studies. Rejuvenation Res 9 2 (2006) 207-210
18. Bureau of Labor Statistics. Occupational Employment Statistics: National Occupational Employment and Wage Estimates, 2006. Welders, Cutters, Solders, and Brazers, U.S. Department of Labor, May 2006. Available at: http://www.bls.gov/oes/2006/may/oes514121.htm accessed 31-3-09.
19. Chase T.N. A gene for Parkinson disease. Arch Neurol 54 9 (1997) 1156-1157
20. Chen C.J., and Liao S.L. Oxidative stress involves in astrocytic alterations induced by manganese. Exp Neurol 175 1 (2002) 216-225
21. Chen M.T., Cheng G.W., Lin C.C., Chen B.H., and Huang Y.L. Effects of acute manganese chloride exposure on lipid peroxidation and alteration of trace metals in rat brain. Biol Trace Elem Res 110 2 (2006) 163-178
22. Chu M.W., Siegmund K.D., Eckstam C.L., Kim J.Y., Yang A.S., Kanel G.C., et al. Lack of increases in methylation at three CpG-rich genomic loci in non-mitotic adult tissues during aging. BMC Med Genet 8 (2007) 50
23. Chu N.S. Effect of levodopa treatment for parkinsonism in welders: a double-blind study. Neurology 63 8 (2004) 1541
24. Clewell H.J., Lawrence G.A., Calne D.B., and Crump K.S. Determination of an occupational exposure guideline for manganese using the benchmark method. Risk Anal 23 5 (2003) 1031-1046
25. Cooper W.C. The health implications of increased manganese in the environment resulting from the combustion of fuel additives: a review of the literature. J Toxicol Environ Health 14 1 (1984) 23-46
26. Dalton T.P., Chen Y., Schneider S.N., Nebert D.W., and Shertzer H.G. Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic Biol Med 37 10 (2004) 1511-1526
27. Dalton T.P., He L., Wang B., Miller M.L., Jin L., Stringer K.F., et al. Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis. Proc Natl Acad Sci USA 102 9 (2005) 3401-3406
28. Davis J.M., Jarabek A.M., Mage D.T., and Graham J.A. The EPA health risk assessment of methylcyclopentadienyl manganese tricarbonyl (MMT). Risk Anal 18 1 (1998) 57-70
29. Deng H., Le W., Shahed J., Xie W., and Jankovic J. Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families. Neurosci Lett 430 1 (2008) 18-22
30. Dick F.D., De P.G., Ahmadi A., Osborne A., Scott N.W., Prescott G.J., et al. Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study. Occup Environ Med 64 10 (2007) 673-680
31. Dick F.D., De P.G., Ahmadi A., Scott N.W., Prescott G.J., Bennett J., et al. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med 64 10 (2007) 666-672
32. Dobson A.W., Erikson K.M., and Aschner M. Manganese neurotoxicity. Ann N Y Acad Sci 1012 (2004) 115-128
33. Ellingsen D.G., Haug E., Ulvik R.J., and Thomassen Y. Iron status in manganese alloy production workers. J Appl Toxicol 23 (2003) 239-247
34. Erikson K.M., and Aschner M. Manganese neurotoxicity and glutamate-GABA interaction. Neurochem Int 43 4-5 (2003) 475-480
35. Erikson K.M., Dorman D.C., Lash L.H., and Aschner M. Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol Sci 97 2 (2007) 459-466
36. Erikson K.M., Dorman D.C., Lash L.H., and Aschner M. Duration of airborne-manganese exposure in rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Neurotoxicology 29 3 (2008) 377-385
37. Feldman R.G. Manganese. Occupational and environmental neurotoxicology (1999), Lippincott-Raven Press, New York, NY p. 168-188
38. Fell J.M., Reynolds A.P., Meadows N., Khan K., Long S.G., Quaghebeur G., et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347 9010 (1996) 1218-1221
39. Fitsanakis V.A., Au C., Erikson K.M., and Aschner M. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int 48 6-7 (2006) 426-433
40. Fitsanakis V.A., Zhang N., Anderson J.G., Erikson K.M., Avison M.J., Gore J.C., et al. Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci 103 1 (2008) 116-124
41. Garcia S.J., Gellein K., Syversen T., and Aschner M. A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol Sci 92 (2006) 516-525
42. Garcia S.J., Gellein K., Syversen T., and Aschner M. Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol Sci 95 (2007) 205-214
43. Gasser T. Update on the genetics of Parkinson's disease. Mov Disord 22 Suppl. 17 (2007) S343-S350
44. Girijashanker K., He L., Soleimani M., Reed J.M., Li H., Liu Z., et al. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol Pharmacol (2008)
45. Guerreiro R.J., Bras J.M., Santana I., Januario C., Santiago B., Morgadinho A.S., et al. Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurol 6 (2006) 24
46. Hamet P., and Tremblay J. Genes of aging. Metabolism 52 10 (Suppl. 2) (2003) 5-9
47. He L., Girijashanker K., Dalton T.P., Reed J., Li H., Soleimani M., et al. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol Pharmacol 70 1 (2006) 171-180
48. Heilig E.A., Thompson K.J., Molina R.M., Ivanov A.R., Brain J.D., and Wessling-Resnick M. Manganese and iron transport across pulmonary epithelium. Am J Physiol Lung Cell Mol Physiol 290 6 (2006) L1247-L1259
49. Ho S.M., Tang W.Y., Belmonte de F.J., and Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66 11 (2006) 5624-5632
50. Iregren A. Psychological test performance in foundry workers exposed to low levels of manganese. Neurotoxicol Teratol 12 6 (1990) 673-675
51. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 64 12 (2005) 2021-2028
52. Kaiser J. Manganese: a high-octane dispute. Science 300 5621 (2003) 926-928
53. Kim Y. High signal intensities on T1-weighted MRI as a biomarker of exposure to manganese. Ind Health 42 2 (2004) 111-115
54. Kirkey K.L., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., and Gorell J.M. Occupational categories at risk for Parkinson's disease. Am J Ind Med 39 6 (2001) 564-571
55. Klos K.J., Chandler M., Kumar N., Ahlskog J.E., and Josephs K.A. Neuropsychological profiles of manganese neurotoxicity. Eur J Neurol 13 10 (2006) 1139-1141
56. Koller W.C., Lyons K.E., and Truly W. Effect of levodopa treatment for Parkinsonism in welders: a double-blind study. Neurology 62 5 (2004) 730-733
57. Krieger D., Krieger S., Jansen O., Gass P., Theilmann L., and Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 346 8970 (1995) 270-274
58. Leavens T.L., Rao D., Andersen M.E., and Dorman D.C. Evaluating transport of manganese from olfactory mucosa to striatum by pharmacokinetic modeling. Toxicol Sci 97 2 (2007) 265-278
59. Lee D.H., O'Connor T.R., and Pfeifer G.P. Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG-->TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells. Nucleic Acids Res 30 16 (2002) 3566-3573
60. Liu L., van G.T., Kadish I., and Tollefsbol T.O. DNA methylation impacts on learning and memory in aging. Neurobiol Aging (2007)
61. Ljung K., and Vahter M. Time to re-evaluate the guideline value for manganese in drinking water?. Environ Health Perspect 115 11 (2007) 1533-1538
62. Loranger S., and Zayed J. Environmental contamination and human exposure assessment to manganese in the St-Lawrence River ecozone (Quebec, Canada) using an environmental fate/exposure model: GEOTOX. SAR QSAR Environ Res 6 1-2 (1997) 105-119
63. Lu C.S., Huang C.C., Chu N.S., and Calne D.B. Levodopa failure in chronic manganism. Neurology 44 9 (1994) 1600-1602
64. Lucchini R., Bergamaschi E., Smargiassi A., Festa D., and Apostoli P. Motor function, olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environ Res 73 1-2 (1997) 175-180
65. Lucchini R., Selis L., Folli D., Apostoli P., Mutti A., Vanoni O., et al. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health 21 2 (1995) 143-149
66. Malecki E.A. Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons. Brain Res Bull 55 2 (2001) 225-228
67. Mao X., Kim B.E., Wang F., Eide D.J., and Petris M.J. A histidine-rich cluster mediates the ubiquitination and degradation of the human zinc transporter, hZIP4, and protects against zinc cytotoxicity. J Biol Chem 282 10 (2007) 6992-7000
68. Martin C.J. Manganese neurotoxicity: connecting the dots along the continuum of dysfunction. Neurotoxicology 27 3 (2006) 347-349
69. Masson L.F., Sharp L., Cotton S.C., and Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 161 10 (2005) 901-915
70. Mena I. The role of manganese in human disease. Ann Clin Lab Sci 4 6 (1974) 487-491
71. Mergler D., and Baldwin M. Early manifestations of manganese neurotoxicity in humans: an update. Environ Res 73 1-2 (1997) 92-100
72. Miller R.L., and Ho S.M. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med 177 6 (2008) 567-573
73. Montgomery Jr. E.B. Heavy metals and the etiology of Parkinson's disease and other movement disorders. Toxicology 97 1-3 (1995) 3-9
74. Morello M., Canini A., Mattioli P., Sorge R.P., Alimonti A., Bocca B., et al. Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. Neurotoxicology 29 1 (2008) 60-72
75. Myers J.E., teWaterNaude J., Fourie M., Zogoe H.B., Naik I., Theodorou P., et al. Nervous system effects of occupational manganese exposure on South African manganese mineworkers. Neurotoxicology 24 4-5 (2003) 649-656
76. National Research Council. Risk assessment in the federal government: managing the process (1983), National Academy Press, Washington, DC
77. Nebert D.W. Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics. Eur J Pharmacol 410 2-3 (2000) 107-120
78. Nebert D.W., and Vesell E.S. Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics. Trends Pharmacol Sci 27 11 (2006) 580-586
79. Nebert D.W., Zhang G., and Vesell E.S. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 40 2 (2008) 187-224
80. Newland M.C. Animal models of manganese's neurotoxicity. Neurotoxicology 20 (1999) 415-432
81. Newland M.C., and Weiss B. Persistent effects of manganese on effortful responding and their relationship to manganese accumulation in the primate globus pallidus. Toxicol Appl Pharmacol 113 1 (1992) 87-97
82. Olanow C.W. Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci 1012 (2004) 209-223
83. Olanow C.W., Good P.F., Shinotoh H., Hewitt K.A., Vingerhoets F., Snow B.J., et al. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 46 2 (1996) 492-498
84. Park E.Y., Hong Y.C., Lee K.H., Im M.W., Ha E., Kim Y.J., et al. Maternal exposure to environmental tobacco smoke, GSTM1/T1 polymorphisms and oxidative stress. Reprod Toxicol 26 3-4 (2008) 197-202
85. Park R.M., Bowler R.M., Eggerth D.E., Diamond E., Spencer K.J., Smith D., et al. Issues in neurological risk assessment for occupational exposures: the Bay Bridge welders. Neurotoxicology 27 3 (2006) 373-384
86. Park R.M., Schulte P.A., Bowman J.D., Walker J.T., Bondy S.C., Yost M.G., et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med 48 1 (2005) 63-77
87. Perera F., Tang W.Y., Herbstman J., Tang D., Levin L., Miller R., et al. Relation of DNA methylation of 5′-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma. PLoS ONE 4 2 (2009) e4488
88. Ravindran C.R., and Ticku M.K. Methylation of NMDA receptor NR2B gene as a function of age in the mouse brain. Neurosci Lett 380 3 (2005) 223-228
89. Reist C., Ozdemir V., Wang E., Hashemzadeh M., Mee S., and Moyzis R. Novelty seeking and the dopamine D4 receptor gene (DRD4) revisited in Asians: haplotype characterization and relevance of the 2-repeat allele. Am J Med Genet B Neuropsychiatr Genet 144B 4 (2007) 453-457
90. Riess O., Kruger R., and Schulz J.B. Spectrum of phenotypes and genotypes in Parkinson's disease. J Neurol 249 Suppl. 3 (2002) III/15-III/20
91. Roels H., Lauwerys R., Genet P., Sarhan M.J., de Fays M., Hanotiau I., et al. Relationship between external and internal parameters of exposure to manganese in workers from a manganese oxide and salt producing plant. Am J Ind Med 11 3 (1987) 297-305
92. Roels H.A., Ghyselen P., Buchet J.P., Ceulemans E., and Lauwerys R.R. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med 49 1 (1992) 25-34
93. Romieu I., Ramirez-Aguilar M., Sienra-Monge J.J., Moreno-Macias H., del Rio-Navarro B.E., David G., et al. GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J 28 5 (2006) 953-959
94. Rossander-Hulten L., Brune M., Sandstrom B., Lonnerdal B., and Hallberg L. Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 54 1 (1991) 152-156
95. Roth J.A., and Garrick M.D. Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem Pharmacol 66 1 (2003) 1-13
96. Russo A.L., Thiagalingam A., Pan H., Califano J., Cheng K.H., Ponte J.F., et al. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 11 7 (2005) 2466-2470
97. Sahni V., Leger Y., Panaro L., Allen M., Giffin S., Fury D., et al. Case report: a metabolic disorder presenting as pediatric manganism. Environ Health Perspect 115 (2007) 1776-1779
98. Salnikow K., and Costa M. Epigenetic mechanisms of nickel carcinogenesis. J Environ Pathol Toxicol Oncol 19 3 (2000) 307-318
99. Salnikow K., and Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 21 1 (2008) 28-44
100. Santamaria A.B., Cushing C.A., Antonini J.M., Finley B.L., and Mowat F.S. State-of-the-science review: does manganese exposure during welding pose a neurological risk?. J Toxicol Environ Health B Crit Rev 10 6 (2007) 417-465
101. Schneider J.S., Decamp E., Koser A.J., Fritz S., Gonczi H., Syversen T., et al. Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates. Brain Res 1118 1 (2006) 222-231
102. Schulte P.A. The contributions of genetics and genomics to occupational safety and health. Occup Environ Med 64 11 (2007) 717-718
103. Shinotoh H., Snow B.J., Hewitt K.A., Pate B.D., Doudet D., Nugent R., et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology 45 6 (1995) 1199-1204
104. Siegmund K.D., Connor C.M., Campan M., Long T.I., Weisenberger D.J., Biniszkiewicz D., et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2 9 (2007) e895
105. Smith D., Gwiazda R., Bowler R., Roels H., Park R., Taicher C., et al. Biomarkers of Mn exposure in humans. Am J Ind Med 50 11 (2007) 801-811
106. Standridge J.S., Bhattacharya A., Succop P., Cox C., and Haynes E. Effect of chronic low level manganese exposure on postural balance: a pilot study of residents in southern ohio. J Occup Environ Med 50 12 (2008) 1421-1429
107. Tamer L., Ercan B., Camsari A., Yildirim H., Cicek D., Sucu N., et al. Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res Cardiol 99 3 (2004) 223-229
108. Taylor M.D., Erikson K.M., Dobson A.W., Fitsanakis V.A., Dorman D.C., and Aschner M. Effects of inhaled manganese on biomarkers of oxidative stress in the rat brain. Neurotoxicology 27 5 (2006) 788-797
109. Thompson K., Molina R.M., Donaghey T., Schwob J.E., Brain J.D., and Wessling-Resnick M. Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J 21 1 (2007) 223-230
110. Wahner A.D., Glatt C.E., Bronstein J.M., and Ritz B. Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease. Neurosci Lett 413 3 (2007) 274-278
111. Wang L.S., Tang J.J., Tang N.P., Wang M.W., Yan J.J., Wang Q.M., et al. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking. Clin Chem Lab Med 46 12 (2008) 1720-1725
112. Wang X., Li G.J., and Zheng W. Upregulation of DMT1 expression in choroidal epithelia of the blood-CSF barrier following manganese exposure in vitro. Brain Res 1097 1 (2006) 1-10
113. Warner T.T., and Schapira A.H. Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 53 Suppl. 3 (2003) S16-S23
114. Waterland R.A. Is epigenetics an important link between early life events and adult disease?. Horm Res 71 Suppl. 1 (2009) 13-16
115. Wilson M.H., Grant P.J., Hardie L.J., and Wild C.P. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J 14 5 (2000) 791-796
116. Zheng Y.X., Chan P., Pan Z.F., Shi N.N., Wang Z.X., Pan J., et al. Polymorphism of metabolic genes and susceptibility to occupational chronic manganism. Biomarkers 7 4 (2002) 337-346